CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers Long-term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS Heart Failure Outcomes With Volume-Guided Management A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: the AVIO trial Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes Evolving insights into the role of local shear stress in late stent failure from neoatherosclerosis formation and plaque destabilization Three-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients

Clinical TrialMarch 17, 2019

JOURNAL:N Engl J Med. Article Link

Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers

DL Bhatt, CV Pollack, JS Lee et al. Keywords: Ticagrelor reversal; oral P2Y12 inhibitor; major bleeding

FULL TEXT PDF